FR2320735A1 - Composition anti-cellulite - Google Patents

Composition anti-cellulite

Info

Publication number
FR2320735A1
FR2320735A1 FR7525069A FR7525069A FR2320735A1 FR 2320735 A1 FR2320735 A1 FR 2320735A1 FR 7525069 A FR7525069 A FR 7525069A FR 7525069 A FR7525069 A FR 7525069A FR 2320735 A1 FR2320735 A1 FR 2320735A1
Authority
FR
France
Prior art keywords
compsns
cellulitis
biguanide
pamoate
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7525069A
Other languages
English (en)
Other versions
FR2320735B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7525069A priority Critical patent/FR2320735A1/fr
Publication of FR2320735A1 publication Critical patent/FR2320735A1/fr
Application granted granted Critical
Publication of FR2320735B1 publication Critical patent/FR2320735B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7525069A 1975-08-12 1975-08-12 Composition anti-cellulite Granted FR2320735A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7525069A FR2320735A1 (fr) 1975-08-12 1975-08-12 Composition anti-cellulite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7525069A FR2320735A1 (fr) 1975-08-12 1975-08-12 Composition anti-cellulite

Publications (2)

Publication Number Publication Date
FR2320735A1 true FR2320735A1 (fr) 1977-03-11
FR2320735B1 FR2320735B1 (fr) 1979-09-14

Family

ID=9159012

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7525069A Granted FR2320735A1 (fr) 1975-08-12 1975-08-12 Composition anti-cellulite

Country Status (1)

Country Link
FR (1) FR2320735A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120165A2 (fr) * 1982-12-10 1984-10-03 Greenway III, Frank L. Préparation et méthode pour provoquer une perte localisée de poids
FR2776189A1 (fr) * 1999-06-09 1999-09-24 Lipha Forme galenique a base de metformine a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
US6031004A (en) * 1997-12-08 2000-02-29 Bristol-Myers Squibb Company Salts of metformin and method
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
WO2001062237A2 (fr) * 2000-02-23 2001-08-30 Orentreich Foundation For The Advancement Of Science, Inc. Methodes et compositions de traitement de l'alopecie et d'autres troubles de l'appareil pilosebace
FR2809310A1 (fr) * 2000-05-26 2001-11-30 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
WO2009137100A2 (fr) * 2008-05-09 2009-11-12 Tolmar, Inc. Proguanil pour le traitement des maladies de peau/des muqueuses
WO2009144527A1 (fr) 2008-06-26 2009-12-03 Laboratorios Silanes, S.A. De C.V. Nouveau sel de metformine glycinate pour régulation de la glycémie
CN111053700A (zh) * 2018-10-17 2020-04-24 程定超 一种二甲双胍抗衰老的护肤品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152181A (en) * 1961-01-18 1964-10-06 Us Vitamin Pharm Corp Alkoxypropylene biguanides
US3183230A (en) * 1961-01-13 1965-05-11 Us Vitamin Pharm Corp Haloaralkyl biguanides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183230A (en) * 1961-01-13 1965-05-11 Us Vitamin Pharm Corp Haloaralkyl biguanides
US3152181A (en) * 1961-01-18 1964-10-06 Us Vitamin Pharm Corp Alkoxypropylene biguanides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.BURGER: "MEDICAL CHEMISTRY", 3ME ED., WILEY, NEW YORK 1970 , VOL. II, PAGES 1178-1179.) *
CHEMICAL ABSTRACTS, VOL. 69 1968 : 85344N *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120165A3 (en) * 1982-12-10 1985-06-19 Frank L. Greenway Iii A preparation and a process for achieving regional weight control
EP0120165A2 (fr) * 1982-12-10 1984-10-03 Greenway III, Frank L. Préparation et méthode pour provoquer une perte localisée de poids
US6031004A (en) * 1997-12-08 2000-02-29 Bristol-Myers Squibb Company Salts of metformin and method
US6284275B1 (en) 1998-08-31 2001-09-04 Andrx Pharmaceuticals, Inc. Controlled release tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
FR2776189A1 (fr) * 1999-06-09 1999-09-24 Lipha Forme galenique a base de metformine a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
US7105573B2 (en) 2000-02-23 2006-09-12 Orentreich Foundation For The Advancement Of Science, Inc. Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
WO2001062237A3 (fr) * 2000-02-23 2002-06-13 Orentreich Foundation For The Methodes et compositions de traitement de l'alopecie et d'autres troubles de l'appareil pilosebace
AU2001239826B2 (en) * 2000-02-23 2006-06-15 Orentreich Foundation For The Advancement Of Science, Inc. Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
WO2001062237A2 (fr) * 2000-02-23 2001-08-30 Orentreich Foundation For The Advancement Of Science, Inc. Methodes et compositions de traitement de l'alopecie et d'autres troubles de l'appareil pilosebace
FR2809310A1 (fr) * 2000-05-26 2001-11-30 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
WO2001091696A2 (fr) * 2000-05-26 2001-12-06 Centre National De La Recherche Scientifique (Cnrs) Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
WO2001091696A3 (fr) * 2000-05-26 2002-06-06 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
US7199159B2 (en) 2000-05-26 2007-04-03 Centre National De La Recherche Scientifique (C.N.R.S.) Use of biguanide derivatives for making a medicine having a wound healing effect
WO2009137100A2 (fr) * 2008-05-09 2009-11-12 Tolmar, Inc. Proguanil pour le traitement des maladies de peau/des muqueuses
WO2009137100A3 (fr) * 2008-05-09 2010-07-22 Tolmar, Inc. Proguanil pour le traitement des maladies de peau/des muqueuses
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
WO2009144527A1 (fr) 2008-06-26 2009-12-03 Laboratorios Silanes, S.A. De C.V. Nouveau sel de metformine glycinate pour régulation de la glycémie
CN111053700A (zh) * 2018-10-17 2020-04-24 程定超 一种二甲双胍抗衰老的护肤品

Also Published As

Publication number Publication date
FR2320735B1 (fr) 1979-09-14

Similar Documents

Publication Publication Date Title
NO165540C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n,n-dimetyl-1-(1-(4-klorfenyl)cyklobutyl)-3-metylbutylamin-hydroklorid-monohydrat.
FR2320735A1 (fr) Composition anti-cellulite
ATE94393T1 (de) Dosisform zur oralen verabreichung des hypoglykaemischen glipizids.
DE59406075D1 (de) Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreitsetzung
IL81573A (en) Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
NO995944L (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
AU7999787A (en) Active compounds for use in the treatment of tumors
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
JPS6483020A (en) Medicinal composition for preventing or treating aids
ATE59550T1 (de) Chlorpheniramine therapie.
FR2345146A1 (fr) Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol
GR3004113T3 (fr)
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
FR2154506A1 (en) Medicaments contg biotin - as hypoglycaemic agents
FR2394292A1 (fr) Chimiotherapeutique nouvelle pour la therapeutique anti-neoplasique, dite " dual therapy "
Doyle Imipramine pamoate in depression.
FR2011993A1 (en) 2-4-thiazolyl benzimidazole derivs anthelmintics
HUT43492A (en) Process for preventing and healing of gastrointestinic damages by using 3-ethoxicarbonil--1,6-dimethil-4-oxo-6,7,8,9-tetrahydro-4-h-pirido-/1,2-a/-pirimidinium-metha sulphate
FR2138603A1 (en) Cytostatic 2,2'-anhydroarabinosylcytosine - esp for treating leukaemia
FR2298333A1 (fr) Medicament destine au betail
FR2014326A1 (en) 2-4-thiazolyl benzimidazole derivs anthelmintics
FR2014402A1 (en) 2-4-thiazolyl benzimidazole derivs anthelmintics
GR3009556T3 (fr)
SU682234A1 (ru) Средство дл предупреждени и устранени побочных реакций при противотуберкулезной терапии "купир
Zapletálek et al. Clomipramine in the treatment of depressions.

Legal Events

Date Code Title Description
ST Notification of lapse